Trexquant Investment’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-17,329
| Closed | -$1.21M | – | 1819 |
|
2022
Q3 | $1.21M | Buy |
17,329
+11,916
| +220% | +$832K | 0.04% | 476 |
|
2022
Q2 | $363K | Sell |
5,413
-20,711
| -79% | -$1.39M | 0.02% | 1018 |
|
2022
Q1 | $2.15M | Buy |
26,124
+23,435
| +872% | +$1.93M | 0.1% | 250 |
|
2021
Q4 | $394K | Buy |
+2,689
| New | +$394K | 0.02% | 777 |
|
2021
Q3 | – | Sell |
-4,850
| Closed | -$783K | – | 1582 |
|
2021
Q2 | $783K | Buy |
+4,850
| New | +$783K | 0.07% | 365 |
|
2021
Q1 | – | Sell |
-9,742
| Closed | -$2.14M | – | 1552 |
|
2020
Q4 | $2.14M | Buy |
+9,742
| New | +$2.14M | 0.23% | 115 |
|
2019
Q4 | – | Sell |
-8,665
| Closed | -$675K | – | 1321 |
|
2019
Q3 | $675K | Buy |
8,665
+5,005
| +137% | +$390K | 0.06% | 374 |
|
2019
Q2 | $377K | Buy |
+3,660
| New | +$377K | 0.03% | 541 |
|
2019
Q1 | – | Sell |
-6,964
| Closed | -$295K | – | 1393 |
|
2018
Q4 | $295K | Buy |
+6,964
| New | +$295K | 0.02% | 787 |
|
2018
Q2 | – | Sell |
-26,650
| Closed | -$818K | – | 1307 |
|
2018
Q1 | $818K | Buy |
+26,650
| New | +$818K | 0.06% | 473 |
|
2017
Q2 | – | Sell |
-42,879
| Closed | -$223K | – | 1260 |
|
2017
Q1 | $223K | Buy |
42,879
+16,447
| +62% | +$85.5K | 0.03% | 912 |
|
2016
Q4 | $126K | Buy |
26,432
+4,599
| +21% | +$21.9K | 0.02% | 894 |
|
2016
Q3 | $144K | Sell |
21,833
-26,345
| -55% | -$174K | 0.03% | 672 |
|
2016
Q2 | $263K | Buy |
+48,178
| New | +$263K | 0.03% | 708 |
|
2016
Q1 | – | Sell |
-29,900
| Closed | -$945K | – | 1232 |
|
2015
Q4 | $945K | Sell |
29,900
-6,200
| -17% | -$196K | 0.08% | 414 |
|
2015
Q3 | $1.24M | Buy |
+36,100
| New | +$1.24M | 0.11% | 331 |
|